Lester W. Schwartz

1.2k total citations
28 papers, 966 citations indexed

About

Lester W. Schwartz is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Pharmacology. According to data from OpenAlex, Lester W. Schwartz has authored 28 papers receiving a total of 966 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 5 papers in Pulmonary and Respiratory Medicine and 4 papers in Pharmacology. Recurrent topics in Lester W. Schwartz's work include Inhalation and Respiratory Drug Delivery (4 papers), Drug-Induced Hepatotoxicity and Protection (3 papers) and Allergic Rhinitis and Sensitization (2 papers). Lester W. Schwartz is often cited by papers focused on Inhalation and Respiratory Drug Delivery (4 papers), Drug-Induced Hepatotoxicity and Protection (3 papers) and Allergic Rhinitis and Sensitization (2 papers). Lester W. Schwartz collaborates with scholars based in United States, United Kingdom and India. Lester W. Schwartz's co-authors include Martin A. Wasserman, Don E. Griswold, P L Simon, D Rachmilewitz, Joseph D. Fondacaro, S J Newsholme, Padma Kumar Narayanan, Carroll E. Cross, David C. McFarland and Marshall S. Scicchitano and has published in prestigious journals such as Gastroenterology, CHEST Journal and Journal of Allergy and Clinical Immunology.

In The Last Decade

Lester W. Schwartz

28 papers receiving 919 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lester W. Schwartz United States 15 290 210 180 173 145 28 966
J Benvéniste France 21 310 1.1× 171 0.8× 263 1.5× 74 0.4× 117 0.8× 45 1.0k
Emile Levy Canada 21 457 1.6× 341 1.6× 123 0.7× 182 1.1× 281 1.9× 41 1.4k
B. Moseley Waite United States 16 337 1.2× 175 0.8× 198 1.1× 214 1.2× 100 0.7× 28 909
Joseph Ravalese United States 6 210 0.7× 299 1.4× 178 1.0× 126 0.7× 430 3.0× 8 1.4k
Momtaz K. Wassef United States 18 364 1.3× 131 0.6× 131 0.7× 264 1.5× 326 2.2× 24 1.4k
Jonathan M. Gerrard United States 20 308 1.1× 158 0.8× 125 0.7× 232 1.3× 182 1.3× 41 1.4k
Michiko Ito Japan 21 328 1.1× 205 1.0× 81 0.5× 288 1.7× 213 1.5× 84 1.3k
Motoharu Kondo Japan 16 169 0.6× 205 1.0× 81 0.5× 62 0.4× 154 1.1× 54 826
A Cole United Kingdom 14 140 0.5× 287 1.4× 143 0.8× 94 0.5× 267 1.8× 25 921
Marika Collin United Kingdom 19 633 2.2× 183 0.9× 242 1.3× 79 0.5× 152 1.0× 24 1.3k

Countries citing papers authored by Lester W. Schwartz

Since Specialization
Citations

This map shows the geographic impact of Lester W. Schwartz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lester W. Schwartz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lester W. Schwartz more than expected).

Fields of papers citing papers by Lester W. Schwartz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lester W. Schwartz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lester W. Schwartz. The network helps show where Lester W. Schwartz may publish in the future.

Co-authorship network of co-authors of Lester W. Schwartz

This figure shows the co-authorship network connecting the top 25 collaborators of Lester W. Schwartz. A scholar is included among the top collaborators of Lester W. Schwartz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lester W. Schwartz. Lester W. Schwartz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dalmas, Deidre A., Lauren A. Tierney, Padma Kumar Narayanan, et al.. (2008). Effects of p38 MAP Kinase Inhibitors on the Differentiation and Maturation of Erythroid Progenitors. Toxicologic Pathology. 36(7). 958–971. 9 indexed citations
2.
Scicchitano, Marshall S., David C. McFarland, Lauren A. Tierney, et al.. (2008). Role of p38 in regulation of hematopoiesis: Effect of p38 inhibition on cytokine production and transcription factor activity in human bone marrow stromal cells. Blood Cells Molecules and Diseases. 40(3). 370–380. 12 indexed citations
3.
Tirmenstein, Mark A., Catherine Hu, Marshall S. Scicchitano, et al.. (2005). Effects of 6-hydroxydopamine on mitochondrial function and glutathione status in SH-SY5Y human neuroblastoma cells. Toxicology in Vitro. 19(4). 471–479. 54 indexed citations
4.
Kerns, William, Lester W. Schwartz, Kerry T. Blanchard, et al.. (2004). Drug-induced vascular injury—a quest for biomarkers. Toxicology and Applied Pharmacology. 203(1). 62–87. 55 indexed citations
5.
Narayanan, Padma Kumar, et al.. (2003). Troglitazone‐induced intracellular oxidative stress in rat hepatoma cells: A flow cytometric assessment. Cytometry Part A. 52A(1). 28–35. 51 indexed citations
6.
Zimmerman, Dawn, Roberta Thomas, Marshall S. Scicchitano, et al.. (2003). Automation of NonisotopicIn SituHybridization. Journal of Histotechnology. 26(3). 181–184. 4 indexed citations
7.
Scicchitano, Marshall S., David C. McFarland, Lauren A. Tierney, Padma Kumar Narayanan, & Lester W. Schwartz. (2003). In vitro expansion of human cord blood CD36+ erythroid progenitors: Temporal changes in gene and protein expression. Experimental Hematology. 31(9). 760–769. 36 indexed citations
8.
Hart, Timothy K., Richard M. Cook, Parnian Zia‐Amirhosseini, et al.. (2001). Preclinical efficacy and safety of mepolizumab (SB-240563), a humanized monoclonal antibody to IL-5, in cynomolgus monkeys. Journal of Allergy and Clinical Immunology. 108(2). 250–257. 182 indexed citations
9.
Newsholme, S J, et al.. (2000). Evaluation of Plasma von Willebrand Factor as a Biomarker for Acute Arterial Damage in Rats. Toxicologic Pathology. 28(5). 688–693. 20 indexed citations
10.
Louden, Calvert, Ponnal Nambi, Mark Pullen, et al.. (2000). Endothelin Receptor Subtype Distribution Predisposes Coronary Arteries to Damage. American Journal Of Pathology. 157(1). 123–134. 19 indexed citations
11.
Newsholme, S J, et al.. (2000). Two‐dimensional electrophoresis of liver proteins: Characterization of a drug‐induced hepatomegaly in rats. Electrophoresis. 21(11). 2122–2128. 52 indexed citations
12.
13.
Schwartz, Lester W., et al.. (1991). Comparative Biochemical and Morphometric Changes Associated with Induction of the Hepatic Mixed Function Oxidase System in the Rat. Toxicologic Pathology. 19(2). 115–122. 12 indexed citations
14.
Rachmilewitz, D, P L Simon, Lester W. Schwartz, et al.. (1989). Inflammatory mediators of experimental colitis in rats. Gastroenterology. 97(2). 326–337. 231 indexed citations
15.
Walker, Richard F., Lester W. Schwartz, & Jeanne M. Manson. (1988). Ovarian effects of an anti-inflammatory-immunomodulatory drug in the rat. Toxicology and Applied Pharmacology. 94(2). 266–275. 7 indexed citations
16.
Walker, Richard F., Lester W. Schwartz, Theodore J. Torphy, John F. Newton, & Jeanne M. Manson. (1988). Ovarian effects of SK&F 86002-A2 in the rat: Site of action. Toxicology and Applied Pharmacology. 94(2). 276–286. 1 indexed citations
17.
Schwartz, Lester W., et al.. (1979). Lung Lining Material As a Chemotactant for Alveolar Macrophages. CHEST Journal. 75(2). 284–288. 3 indexed citations
18.
Last, Jerold A., et al.. (1977). Glycoprotein Secretion by Tracheal Explants Cultured from Rats Exposed to Ozone 1– 2. American Review of Respiratory Disease. 116(4). 695–703. 46 indexed citations
19.
Henrickson, Roy V., et al.. (1975). Coccidioidomycosis in a Rhesus Monkey. Journal of the American Veterinary Medical Association. 167(7). 657–661. 3 indexed citations
20.
Sadove, Max S. & Lester W. Schwartz. (1958). An Evaluation of Buffered Versus Nonbuffered Acetylsalicylic Acid. Postgraduate Medicine. 24(2). 183–188. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by J Benvéniste Breakdown of academic impact, for papers by Emile Levy Breakdown of academic impact, for papers by B. Moseley Waite Breakdown of academic impact, for papers by Joseph Ravalese Breakdown of academic impact, for papers by Momtaz K. Wassef Breakdown of academic impact, for papers by Jonathan M. Gerrard Breakdown of academic impact, for papers by Michiko Ito Breakdown of academic impact, for papers by Motoharu Kondo Breakdown of academic impact, for papers by A Cole Breakdown of academic impact, for papers by Marika Collin
Rankless by CCL
2026